CTOs on the Move

ASP Events

www.asp.com

 
Advanced Sterilization Products (ASP) your leaders in sterilization. To protect patients during their most critical moments | Homepage | Irvine CA United States
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.asp.com
  • 33, Technology Drive
    Irvine, CA USA 92618
  • Phone: 800.595.0200

Executives

Name Title Contact Details
Philip Genever-Watling
Chief Information Security Officer Profile

Similar Companies

The Hydropothecary

The Hydropothecary is a licensed producer and distributor of medical marijuana under Health Canada`s Access to Cannabis for Medical Purposes Regulations (ACMPR). We are committed to medical excellence and achieve this through our growing techniques, process control, quality assurance testing, robust research and development, and by offering an exceptional customer service experience. We are proud of our company`s remarkable growth thus far and look forward to our continued expansion with the construction of a new greenhouse which will boast an additional 250,000 sq/ft in 2018. We are constantly seeking skilled, energetic and highly focused p-professionals who would like the opportunity to be a part of our team and of an exciting industry that is constantly evolving.

Pharmachem Labs

Pharmachem Laboratories, Inc., is a leading manufacturer and supplier of value-added nutritional ingredients and bulk raw materials. We offer an exclusive list of trademarks and catalogue of products, as well as custom-manufacturing, and research and

SpaLab

SpaLab is a San Marcos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Viatris

Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.

Olema

Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. At Olema we leverage the exquisite knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development.